• 제목/요약/키워드: NFATc1

검색결과 103건 처리시간 0.02초

치주인대세포의 골모세포 분화에서 NFATc1의 역할 (The Role of NFATc1 on Osteoblastic Differentiation in Human Periodontal Ligament Cells)

  • 이상임
    • 치위생과학회지
    • /
    • 제15권4호
    • /
    • pp.488-494
    • /
    • 2015
  • 치주인대세포의 효과적인 조절은 성공적인 치주 조직 재생에 중요한 역할을 한다. NFATc1의 활성화가 골모세포에서 분화를 자극하지만, 치주인대세포가 골모세포로 분화하는 과정에서 NFATc1의 역할은 아직 보고되지 않았다. 본 연구는 hPDLCs가 골모세포로 분화하는 동안 NFATc1의 mRNA의 발현과 단백질 발현이 유도됨을 처음으로 확인하였다. CsA에 의한 NFATc1의 억제는 세포증식을 감소시켰다. 게다가, CsA를 처리한 결과, 분화표지자, ALP activity 및 광화결정형성을 감소시켰다. 이러한 연구 결과는 NFATc1이 치주 재생을 위한 골모세포 분화에 중요한 조절자 역할을 할 수 있을 것으로 생각된다.

Regulator of calcineurin 1-4과 파골세포 분화의 관련성 (Relationship between the Regulator of Calcineurin 1-4 Isoform and In Vitro Osteoclast Differentiation)

  • 박경록
    • 생명과학회지
    • /
    • 제25권2호
    • /
    • pp.223-230
    • /
    • 2015
  • RCAN1은 calcineurin을 억제하는 내인성 단백질로 calcineurin-NFATc1 신호전달 경로와 관련된 질환의 병인에 중요한 역할을 담당한다. 특히 RCAN1-4 아형 유전자의 경우 NFATc1 전사인자에 의해 조절된다. RANKL 자극은 calcineurin-NFATc1 경로로 파골세포 분화를 유도하는데, RCAN1과 파골세포의 분화에 관련된 연구는 보고 된 바 없다. 따라서 본 연구는 RANKL 처리에 의해 파골세포 분화가 유도될 때 RCAN1이 calcineurin-NFATc1 경로에 미치는 영향을 in vitro에서 조사했다. 마우스로부터 분리한 골수단핵세포에 RANKL을 처리하여 파골세포 분화를 유도했다. RANKL 처리 후 조사 대상 유전자의 mRNA 발현과 단백질 발현을 각각 RT-PCR과 Western blot로써 측정했다. 마우스 RCAN1-4 vector를 파골전구세포인 RAW 264.7 단핵세포주와 골수단핵세포에 형질도입(transfection)시켜 RCAN1-4 유전자의 과발현을 유도했다. 형질도입 후 파골세포 분화의 형태적 변화는 TRAP 염색을 통해 관찰했다. RANKL 처리 후 NFATc1, calcineurin, RCAN1-4 mRNA 발현은 크게 증가했다. 단백질 발현의 경우 NFATc1과 RCAN1은 증가했으나 calcineurin은 대조군과 차이가 없었다. RCAN1-4 유전자의 과발현 유도 시 RCAN1-4 mRNA는 크게 증가되었으나 RCAN1 단백질 발현은 증가되지 않았다. 특히 RANKL 존재 시 RCAN1 유전자를 knock-down시켜도 RCAN1 발현은 정상적으로 유지되었다. 한편, NFATc1 발현은 과발현 유도시 감소했고 knock-down 유도 시 증가하는 경향을 보였다. RCAN1-4 유전자 과발현을 유도한 골수단핵세포에서 배양 5일 후 파골세포 분화는 대조군과 차이가 없었다. 이러한 결과는 RANKL에 의한 파골세포 분화 시 RCAN1이 calcineurin-NFATc1 경로를 통해 파골세포 분화에 미치는 영향은 제한적일 것으로 사료된다.

NFATc1 and NFATc3 is Involved in the Expression of Receptor Activator of NF-${\kappa}B$ Ligand in Activated T Lymphocytes

  • Heo, Sun-Jae;Park, Hyun-Jung;Baek, Jeong-Hwa
    • International Journal of Oral Biology
    • /
    • 제38권1호
    • /
    • pp.37-42
    • /
    • 2013
  • Receptor activator of NF-${\kappa}B$ ligand (RANKL) is an essential cytokine for osteoclast differentiation, activation and survival. T lymphocytes such as $T_{17}$ cells, a subset of T helper cells that produce IL-17, play an important role in rheumatoid arthritic bone resorption by producing inflammatory cytokines and RANKL. It has not yet been clearly elucidated how T cell activation induces RANKL expression. T cell receptor activation induces the activation of nuclear factor of activated T cell (NFAT) and expression of its target genes. In this study, we examined the role of NFAT in T cell activation-induced RANKL expression. EL-4, a murine T lymphocytic cell line, was used. When T cell activation was induced by phorbol 12-myristate 13-acetate (PMA) and ionomycin, RANKL expression increased in a time-dependent manner. In the presence of cyclosporin, an inhibitor of NFAT activation, this PMA/ionomycin-induced RANKL expression was blocked. Overexpression of either NFATc1 or NFATc3 induced RANKL expression. Chromatin immunoprecipitation results demonstrated that PMA/ionomycin treatment induced the binding of NFATc1 and NFATc3 to the mouse RANKL gene promoter. These results suggest that NFATc1 and NFATc3 mediates T cell receptor activation-induced RANKL expression in T lymphocytes.

IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-κB/NFATc1 signaling

  • Kim, Inyoung;Kim, Jung Ha;Kim, Kabsun;Seong, Semun;Lee, Keun-Bae;Kim, Nacksung
    • BMB Reports
    • /
    • 제54권9호
    • /
    • pp.482-487
    • /
    • 2021
  • Interferon regulatory factors (IRFs) play roles in various biological processes including cytokine signaling, cell growth regulation and hematopoietic development. Although it has been reported that several IRFs are involved in bone metabolism, the role of IRF2 in bone cells has not been elucidated. Here, we investigated the involvement of IRF2 in RANKL-induced osteoclast differentiation. IRF2 overexpression in osteoclast precursor cells enhanced osteoclast differentiation by regulating the expression of NFATc1, a master regulator of osteoclastogenesis. Conversely, IRF2 knockdown inhibited osteoclast differentiation and decreased the NFATc1 expression. Moreover, IRF2 increased the translocation of NF-κB subunit p65 to the nucleus in response to RANKL and subsequently induced the expression of NFATc1. IRF2 plays an important role in RANKL-induced osteoclast differentiation by regulating NF-κB/NFATc1 signaling pathway. Taken together, we demonstrated the molecular mechanism of IRF2 in osteoclast differentiation, and provide a molecular basis for potential therapeutic targets for the treatment of bone diseases characterized by excessive bone resorption.

녹용 물 추출물의 파골세포 분화 억제효과 (Effect of Water Extract of Deer Antler in Osteoclast Differentiation)

  • 곽한복;김주호;김동주;권영미;오재민;김윤경
    • 동의생리병리학회지
    • /
    • 제22권4호
    • /
    • pp.891-895
    • /
    • 2008
  • Natural substances have recently received much attention as therapeutic drugs to prevent many diseases in humans because they avoid the many side effects of treatment with chemical compounds. We examined the effect of water extract of deer antler in RANKL-induced osteoclast differentiation. The effects of water extract of deer antler in osteoclast differentiation were determined by culture of bone marrow macrophages (BMMs). The mRNA expression levels of c-Fos, NFATc1, TRAP, and GAPDH in BMMs were analyzed by RT-PCR. Cell lysates were obtained from the treated cells, the expression levels of c-Fos and NFATc1 were determined by western blotting with antibodies for c-Fos and NFATc1. Water extract of deer antler greatly inhibited RANKL-mediated osteoclast differentiation in osteoclast precursors without cytotoxicity. Water extract of deer antler inhibited the expression of c-Fos and NFATc1 in BMMs treated with RANKL. Our findings suggest that water extract of deer antler inhibited osteoclast differentiation by suppressing c-Fos and NFATc1 expression in response to RANKL. These results demonstrate that water extract of deer antler may be a useful the treatment of bone-related disease such as osteoporosis.

Modified simulated body fluid에 침전한 티타늄 표면에서 침전 기간에 따라 나타나는 파골 세포의 분화억제 양상 (Inhibition of Osteoclast differentiation based on precipitation time of titanium surfaces immersed in modified simulated body fluid)

  • 장현민;허성주;김성균;곽재영
    • 대한치과보철학회지
    • /
    • 제57권2호
    • /
    • pp.142-149
    • /
    • 2019
  • 목적: 본 연구의 목적은 티타늄 디스크를 Modified simulated body fluid (mSBF)에 침전시켰을 때, 침전 시킨 기간에 따른 파골 세포 분화 억제 변화 양상을 알아보는 것이다. 재료 및 방법: Machined surface와 anodized surface를 가진 티타늄 합금(Ti grade III)디스크를 각각 증류수와 mSBF에 침전 시켰다. 침전 기간은 7일, 14일, 21일, 28일 진행하였으며, 각각의 기간 동안 대조군은 증류수에 침전하였다. 파골 세포로 분화 가능한 RAW 264.7 세포를 점주하여 침전 기간에 따른 부착된 세포 수 측정, TRAP 활성 측정, western blot을 통한 NFATc1의 발현양상을 측정하였다. 결과: Machined surface와 anodized surface 모두에서 mSBF에14일 이상 침전하였을 때, 파골 세포의 분화를 억제하는 능력이 통계적으로 유의하게 나타났다. 침전 기간과 세포의 부착은 상관관계가 없었다. 14일 이상 침전시켰을 때, TRAP 활성은 감소되었으며, NFATc1의 발현은 억제되었다. 14일 이상 침전 시켰을 때, TRAP활성 감소 및 NFATc1 발현 억제 양상은 변함이 없었다. 결론: 티타늄 합금 디스크를 14일 이상 mSBF에 침전시키면 RAW 264.7 세포가 파골 세포로 분화하는 것을 막을 수 있다. 침전기간이 증가해도 분화 억제 양상은 변화하지 않는다.

Parthenolide inhibits osteoclast differentiation and bone resorbing activity by down-regulation of NFATc1 induction and c-Fos stability, during RANKL-mediated osteoclastogenesis

  • Kim, Ju-Young;Cheon, Yoon-Hee;Yoon, Kwon-Ha;Lee, Myeung Su;Oh, Jaemin
    • BMB Reports
    • /
    • 제47권8호
    • /
    • pp.451-456
    • /
    • 2014
  • Parthenolide, a natural product derived from Feverfew, prevents septic shock and inflammation. We aimed to identify the effects of parthenolide on the RANKL (receptor activator of $NF-{\kappa}B$ ligand)-induced differentiation and bone resorbing activity of osteoclasts. In this study, parthenolide dose-dependently inhibited RANKL-mediated osteoclast differentiation in BMMs, without any evidence of cytotoxicity and the phosphorylation of p38, ERK, and $I{\kappa}B$, as well as $I{\kappa}B$ degradation by RANKL treatment. Parthenolide suppressed the expression of NFATc1, OSCAR, TRAP, DC-STAMP, and cathepsin K in RANKL-treated BMMs. Furthermore, parthenolide down-regulated the stability of c-Fos protein, but could not suppress the expression of c-Fos. Overexpression of NFATc1 and c-Fos in BMMs reversed the inhibitory effect of parthenolide on RANKL-mediated osteoclast differentiation. Parthenolide also inhibited the bone resorbing activity of mature osteoclasts. Parthenolide inhibits the differentiation and bone-resolving activity of osteoclast by RANKL, suggesting its potential therapeutic value for bone destructive disorders associated with osteoclast-mediated bone resorption.

용부탕의 파골세포 분화 억제와 골 흡수 억제효과 (Inhibitory Effects of Yongbu-tang on Osteoclast Differentiation and Bone Resorption)

  • 이정주;조소현;박민철;조은희
    • Journal of Acupuncture Research
    • /
    • 제32권3호
    • /
    • pp.27-40
    • /
    • 2015
  • Objectives : This study was performed to evaluate the effects of water extract of Cervi Parvum Cornu(CPC), Aconiti Lateralis Radix Preparata(ALR), and Yongbu-tang(YBT) on suppression of the receptor activator of nuclear factor kappa-B ligand(RANKL)-induced osteoclast differentiation and bone resorption. Methods : The effects of CPC, ALR, YBT extracts on osteoclast differentiation were determined by culture of bone marrow macrophage(BMM). The mRNA expression levels of the nuclear factor of activated T-cells cytoplasmic 1(NFATc1), c-Fos and tartrate-resistant acid phosphatase(TRAP) in BMMs were analyzed by reverse transcriptase polymerase chain reaction(RT-PCR). Similarly, the protein expression levels of NFATc1, c-Fos, mitogen-activated protein kinase(MAPK)s and ${\beta}$-actin in cell lysates were measured by western blotting. In addition, effects of CPC, ALR and YBT extracts were determined by means of Lipopolysaccharide(LPS)-induced bone-loss with mice. Results : CPC, ALR and YBT extracts showed remarkable inhibition on RANKL-induced osteoclast differentiation without cytotoxicity. CPC and ALR extracts significantly reduced the protein expression level of NFATc1. YBT extract significantly reduced the mRNA expression levels of c-Fos, NFATc1 and the protein expression levels of c-Fos, NFATc1, AKT, p38, c-Jun N-terminal kinase(JNK). Further, YBT extract suppressed degradation of$ I-{\kappa}B$. And ALR extract significantly restored the bone erosion by LPS treatment in mice. Conclusions : YBT extract showed more remarkable inhibition on osteoclast differentiation than CPC and ALR extracts in vitro. ALR extract showed remarkable inhibition on bone resorption in vivo. Thus, YBT extract can be a useful treatment for bone-loss diseases such as osteoporosis.

Dehydrocostus lactone inhibits NFATc1 via regulation of IKK, JNK, and Nrf2, thereby attenuating osteoclastogenesis

  • Lee, Hye In;Lee, Gong-Rak;Lee, Jiae;Kim, Narae;Kwon, Minjeong;Kim, Hyun Jin;Kim, Nam Young;Park, Jin Ha;Jeong, Woojin
    • BMB Reports
    • /
    • 제53권4호
    • /
    • pp.218-222
    • /
    • 2020
  • Excessive and hyperactive osteoclast activity causes bone diseases such as osteoporosis and periodontitis. Thus, the regulation of osteoclast differentiation has clinical implications. We recently reported that dehydrocostus lactone (DL) inhibits osteoclast differentiation by regulating a nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1), but the underlying mechanism remains to be elucidated. Here we demonstrated that DL inhibits NFATc1 by regulating nuclear factor-κB (NF-κB), activator protein-1 (AP-1), and nuclear factor-erythroid 2-related factor 2 (Nrf2). DL attenuated IκBα phosphorylation and p65 nuclear translocation as well as decreased the expression of NF-κB target genes and c-Fos. It also inhibited c-Jun N-terminal kinase (JNK) but not p38 or extracellular signal-regulated kinase. The reporter assay revealed that DL inhibits NF-κB and AP-1 activation. In addition, DL reduced reactive oxygen species either by scavenging them or by activating Nrf2. The DL inhibition of NFATc1 expression and osteoclast differentiation was less effective in Nrf2-deficient cells. Collectively, these results suggest that DL regulates NFATc1 by inhibiting NF-κB and AP-1 via down-regulation of IκB kinase and JNK as well as by activating Nrf2, and thereby attenuates osteoclast differentiation.

사람 치주인대세포에서 Lipopolysaccharide와 니코틴으로 유도된 iNOS와 COX-2 발현에 NFATc의 관여 (NFATc Mediates Lipopolysaccharide and Nicotine-Induced Expression of iNOS and COX-2 in Human Periodontal Ligament Cells)

  • 이상임;유지수
    • 치위생과학회지
    • /
    • 제15권6호
    • /
    • pp.753-760
    • /
    • 2015
  • 숙주 면역 반응과 면역 체계는 치주 질환에 대한 개인의 감수성의 주요 원인이다. 세균 감염과 흡연은 치주 조직의 파괴의 원인과 진행에 관여하는 중요한 환경 위험 요인이다. 따라서, 본 연구는 사람 치주인대세포에서 LPS와 니코틴이 전염증성 사이토카인인 iNOS/COX-2의 발현과 NO/$PGE_2$ 생산에 미치는 영향을 알아보고 NFATc1가 어떤 기전으로 항염작용을 하는지 밝히고자 하였다. LPS와 니코틴을 처리한 사람 치주인대세포에서 iNOS/COX-2의 발현과 함께 NO/$PGE_2$ 생산은 증가되었다. NFATc1 inhibitor인 CsA는 LPS와 니코틴에 의해 유도되는 iNOS/COX-2의 발현과 함께 NO/$PGE_2$ 생산을 감소시켰다. 이러한 연구 결과로 볼 때, NFAT signaling pathway가 LPS와 니코틴에 의한 iNOS/COX-2의 발현을 조절하여 NO/$PGE_2$ 매개 염증에 대해 방어할 수 있다고 생각된다.